A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT06533644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Multicenter, Dose-Escalation and Dose Optimization Study of SYNC-T Therapy SV-102 for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study identification
- NCT ID
- NCT06533644
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Syncromune, Inc.
- Industry
- Enrollment
- 91 participants
Conditions and interventions
Interventions
- Partial Oncolysis Procedure
- SV-102 Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2025
- Primary completion
- Apr 13, 2028
- Completion
- Apr 13, 2028
- Last update posted
- May 17, 2026
2025 – 2028
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | Not yet recruiting |
| University of Arizona Cancer Center | Tucson | Arizona | 85719 | Recruiting |
| University of California-Davis | Sacramento | California | 95817 | Not yet recruiting |
| Mayo Clinic | Jacksonville | Florida | 32224 | Not yet recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| University of Chicago | Chicago | Illinois | 60637 | Not yet recruiting |
| Duly Health | Lisle | Illinois | 60532 | Recruiting |
| Wichita Urology | Wichita | Kansas | 67226 | Recruiting |
| Michigan Institute of Urology | Troy | Michigan | 48084 | Recruiting |
| Mercy Hospital | St Louis | Missouri | 63141 | Recruiting |
| University of Nebraska Medical Center | Omaha | Nebraska | 68105 | Recruiting |
| Northwell Health | Lake Success | New York | 11042 | Recruiting |
| NYU Langone | New York | New York | 10016 | Recruiting |
| Weill Cornell | New York | New York | 10065 | Recruiting |
| Ohio State University | Columbus | Ohio | 43201 | Not yet recruiting |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| Houston Metro Urology | Houston | Texas | 77027 | Not yet recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06533644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06533644 live on ClinicalTrials.gov.